<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Discovery Bit | Emma Ava | Activity</title>
	<link>https://www.discoverybit.com/members/novellacatt83/activity/</link>
	<atom:link href="https://www.discoverybit.com/members/novellacatt83/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Emma Ava.</description>
	<lastBuildDate>Wed, 03 Jun 2026 12:27:46 -0600</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">7f0d05f87e123745c22fb027496c93a8</guid>
				<title>Emma Ava posted an update in the group Product: The US FDA Has Approved The First Drug To Treat [&#133;]</title>
				<link>https://www.discoverybit.com/activity/p/36154/</link>
				<pubDate>Mon, 03 Feb 2020 19:38:34 -0600</pubDate>

									<content:encoded><![CDATA[<p><a href="//www.discoverybit.com/activity/p/35579/" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank">The US FDA</a> Has Approved The First Drug To Treat Life-Threatening Peanut Allergies In Children Btw Ages 4 To 17. The Drug, AR101, Or Palforzia, Is Said To Increase Tolerance To Small  Quantities Of Peanuts, Decreasing The Risk Of Reaction To Accidental Exposure. A Million Kids In US Have Peanut Allergy, With 1 Out Of 5 Outgrowing It. </p>
<div class="bpfb_final_link">
<div class="bpfb_link_preview_container">
		<a href="https://nypost.com/2020/02/03/fda-approves-first-drug-for-treatment-of-peanut-allergy-in-children/" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank"><img loading="lazy" src="https://www.discoverybit.com/dbu/2024/09/Groups-Image-4.jpg" /></a>
	</div>
<div class="bpfb_link_contents">
<div class="bpfb_link_preview_title">F&hellip;</div>
</div>
</div>
<p><span class="activity-read-more" id="activity-read-more-36154"><a href="https://www.discoverybit.com/activity/p/36154/" rel="ugc follow noopener noreferrer" data-wpel-link="internal" target="_self"></a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3db8a6645b2945e621f832a307c9a706</guid>
				<title>Emma Ava posted an update in the group Health: US FDA Has Approved The First Device That Can Treat ADHD In [&#133;]</title>
				<link>https://www.discoverybit.com/activity/p/35579/</link>
				<pubDate>Tue, 23 Apr 2019 01:49:07 -0600</pubDate>

									<content:encoded><![CDATA[<p><a href="//www.discoverybit.com/activity/p/35496/" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank">US FDA</a> Has Approved The First Device That Can Treat ADHD In 5-7 Years Old Kids. The Device, Monarch External Trigeminal Nerve Stimulation System (eTNS), Works By Sending Low-Level Electrical Pulses To The Brain Part Responsible For ADHD Symptoms. The Pocket-Size Device, Which Can be Gotten By Prescription, Cost About $1000. </p>
<div class="bpfb_final_link">
<div class="bpfb_link_preview_container">
		<a href="https://www.cnn.com/2019/04/20/health/adhd-treatment-etns-device-fda-bn/index.html" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank"><img loading="lazy" src="https://cdn.cnn.com/cnnnext/dam/assets/121008175739-children-adhd-super-tease.jpg" /></a>
	</div>
<div class="bpfb_link_contents">
<div class="bpfb_link_preview_title">ADHD&hellip;</div>
</div>
</div>
<p><span class="activity-read-more" id="activity-read-more-35579"><a href="https://www.discoverybit.com/activity/p/35579/" rel="ugc follow noopener noreferrer" data-wpel-link="internal" target="_self"></a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>